SHH and neoplasm: Fan jiajun et al. have reported that vismodegib, an inhibitor of SHH pathway, had only a slight anti-tumor effect on A549 and NCI-H1975 lung adenocarcinoma cells, with Gli2 overexpressed and autophagy activity increased [27].